… gefitinib treatment in never-smokers and in patients of Asian origin. Here, we review the clinical
experience with gefitinib … remains for clinical development of gefitinib in selected patients. …

… in persons with lung cancer. Many of the principles of management relevant to gefitinib are
distinct … practical guidelines on the use of gefitinib in patients with non–small-cell lung cancer. …

… Conference on Lung Cancer, the First-SIGNAL study, oral gefitinib confirmed an improvement
in progression-free survival compared to first-line chemotherapy in patients with EGFR …

… a fraction of patients with NSCLC progressing after chemotherapy experience both a
decrease in lung cancer symptoms and radiographic tumor shrinkages with gefitinib.ObjectiveTo …

… This review discusses the use of gefitinib in Asian patients with advanced NSCLC using
the extensive clinical data available and also summarizes data on the discovery of the EGFR …

… Fifteen of the 79 patients who received gefitinib treatment in our institution had clinically
detectable BM at the time of gefitinib induction. Patient characteristics are shown in Table 1. …

… Hospital Organization Hokkaido Cancer Center, Sapporo City … was performed during gefitinib
treatment in any of the patients, … cessation of gefitinib, followed by resumption of gefitinib. …

… activity and safety of gefitinib in NSCLC patients with brain metastases. Patients and methods:
From January 2001 to May 2003, 41 consecutive NSCLC patients with measurable brain …

… Lung cancer is the leading cause of cancer death worldwide, and approximately 80% of
cases are non–small-cell lung cancer (NSCLC). Many patients with NSCLC have advanced …

… that gefitinib has potential for treating lung cancers that are … Therefore, 98 patients were
included in this analysis. The … Eleven patients were labeled as having non–small cell lung cancer …